Co-Founders & Directors Invest $300K in Recent Private Placement
CALC has more than doubled off its 52-week low of $0.461.
Summary
CalciMedica's co-founders and directors, Eric Roberts and Rachel Leheny, invested a combined $300,000 in the company's recent private placement, signaling strong insider confidence.
Key Events · Ownership and Investor Activity · CALC
-
Significant Insider Investment
Co-founders and directors Eric Roberts and Rachel Leheny collectively purchased 373,458 units in the recent private placement for approximately $300,000.
-
Participation in Recent Financing
This investment was part of the private placement announced on June 24, 2026, which secured up to $49 million for the company.
-
Increased Beneficial Ownership
Eric Roberts now beneficially owns 6.4% of the company, and Rachel Leheny owns 6.3%, reflecting their continued significant stake.
Analysis · CALC · Life Sciences
This Schedule 13D/A reveals that co-founders and managing directors Eric Roberts and Rachel Leheny collectively invested approximately $300,000 in CalciMedica's recent private placement. This significant insider participation, representing nearly 2% of the company's market capitalization, demonstrates strong conviction from key leadership following the company's recent financing and clinical trial updates. It provides more complete detail than the previously reported Form 4.
At the time of this filing, CALC was trading at $0.99 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.3M. The 52-week trading range was $0.46 to $7.20. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.